Literature DB >> 14614623

Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia.

Susanne Schweitzer-Krantz1.   

Abstract

UNLABELLED: Galactosaemia due to galactose-1-phosphate uridyltransferase deficiency is a rare disease (1:40,000). Nationwide newborn screening for galactosaemia is performed in many countries; however, several countries do not screen for galactosaemia due to early manifestation of clinical symptoms and low incidence of the disease. In a German retrospective study, 148 galactosaemic patients born between 1955 and 1995, were evaluated. At least in Germany, newborn screening for galactosaemia, performed at day 5, was able to reduce or prevent the acute morbidity and mortality of the disease. The results should be even better if newborn screening takes place at day 3 using combined substrate screening and enzymatic testing for galactose-1-phosphate-uridyltransferase deficiency.
CONCLUSION: Newborn screening for classical galactosaemia does not change the long-term complications of the disease such as speech disorders, mental retardation, ataxia and in females hypergonadotropic hypogonadism.

Entities:  

Mesh:

Year:  2003        PMID: 14614623     DOI: 10.1007/s00431-003-1352-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

Review 1.  Newborn mass screening for galactosemia.

Authors:  S Schweitzer
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

2.  A simple spot screening test for galactosemia.

Authors:  E Beutler; M C Baluda
Journal:  J Lab Clin Med       Date:  1966-07

3.  Unusual late neurological sequelae in galactosaemia.

Authors:  J E Jan; R A Wilson
Journal:  Dev Med Child Neurol       Date:  1973-02       Impact factor: 5.449

4.  Clouds over galactosaemia.

Authors: 
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

5.  Galactosaemia: results of the British Paediatric Surveillance Unit Study, 1988-90.

Authors:  M M Honeyman; A Green; J B Holton; J V Leonard
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

6.  Colorimetric determination of galactose and galactose-1-phosphate from dried blood.

Authors:  F Diepenbrock; R Heckler; H Schickling; T Engelhard; D Bock; J Sander
Journal:  Clin Biochem       Date:  1992-02       Impact factor: 3.281

7.  A new method of screening for inherited disorders of galactose metabolism.

Authors:  K Paigen; F Pacholec; H L Levy
Journal:  J Lab Clin Med       Date:  1982-06

8.  Developmental aspects of galactosemia from infancy to childhood.

Authors:  K Fishler; R Koch; G N Donnell; E Wenz
Journal:  Clin Pediatr (Phila)       Date:  1980-01       Impact factor: 1.168

9.  Galactosemia: how does long-term treatment change the outcome?

Authors:  R Gitzelmann; B Steinmann
Journal:  Enzyme       Date:  1984

10.  [Long-term results in children with classical galactosemia].

Authors:  S Scheibenreiter; E Knoll; K Widhalm
Journal:  Wien Klin Wochenschr       Date:  1992       Impact factor: 1.704

View more
  21 in total

1.  Newborn screening.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2010-05

2.  The neuropsychological profile of galactosaemia.

Authors:  Claire M Doyle; Shelley Channon; Danuta Orlowska; Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

3.  Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers.

Authors:  Emily C Lisi; Shawn E McCandless
Journal:  J Genet Couns       Date:  2015-08-29       Impact factor: 2.537

4.  Discovery of novel inhibitors of human galactokinase by virtual screening.

Authors:  Xin Hu; Ya-Qin Zhang; Olivia W Lee; Li Liu; Manshu Tang; Kent Lai; Matthew B Boxer; Matthew D Hall; Min Shen
Journal:  J Comput Aided Mol Des       Date:  2019-02-26       Impact factor: 3.686

5.  Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King's College Hospital experience.

Authors:  Robert Hegarty; Nedim Hadzic; Paul Gissen; Anil Dhawan
Journal:  Eur J Pediatr       Date:  2015-04-24       Impact factor: 3.183

Review 6.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

7.  Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes.

Authors:  Patricia P Jumbo-Lucioni; Kathryn Garber; John Kiel; Ivo Baric; Gerard T Berry; Annet Bosch; Alberto Burlina; Ana Chiesa; Maria Luz Couce Pico; Sylvia C Estrada; Howard Henderson; Nancy Leslie; Nicola Longo; Andrew A M Morris; Carlett Ramirez-Farias; Susanne Schweitzer-Krantz; Susanne Scheweitzer-Krantz; Catherine Lynn T Silao; Marcela Vela-Amieva; Susan Waisbren; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2012-03-27       Impact factor: 4.982

8.  In vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry.

Authors:  Leslie Frost; Muhammad Chaudhry; Tiffany Bell; Menashi Cohenford
Journal:  Anal Biochem       Date:  2010-11-26       Impact factor: 3.365

9.  Biochemical changes and clinical outcomes in 34 patients with classic galactosemia.

Authors:  Tatiana Yuzyuk; Krista Viau; Ashley Andrews; Marzia Pasquali; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2018-01-19       Impact factor: 4.982

10.  Communication of genetic information by other health professionals: the role of the genetic counsellor in specialist clinics.

Authors:  Rosie O'Shea; Anne Marie Murphy; Eileen Treacy; Sally Ann Lynch; Kathryn Thirlaway; Debby Lambert
Journal:  J Genet Couns       Date:  2011-01-06       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.